Overview:

Summary

Publisher has released its latest research on a key segment within the medical equipment industry. The “US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015” report is an essential source of data and analysis on the US hip and knee implants market with complete coverage by categories. This medical device report on hip and knee implants provides market landscape, competitive landscape and market trends information on six market categories – primary hip replacement, partial hip replacement, revision hip replacement, primary knee replacement, partial knee replacement and revision knee replacement. The report identifies the key trends shaping and driving the dynamism in the US hip and knee implants market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the US hip and knee implants market.

Scope

- The report provides market size data and information on two hip and knee implants market categories – primary hip replacement, partial hip replacement, revision hip replacement, primary knee replacement, partial knee replacement and revision knee replacement.
- Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the US hip and knee implants market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the US hip and knee implants market in the long run.
- In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. Key companies covered include Zimmer, Stryker and Depuy.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the US hip and knee implants Market.
- Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the US hip and knee implants market in future.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- What’s the next being thing in the US hip and knee implants technology landscape? – Identify, understand and capitalize.

Companies Mentioned

Zimmer Holdings, Inc.
Stryker Corporation
DePuy, Inc.
Biomet, Inc.
Smith & Nephew Plc
Wright Medical Group, Inc.

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 Disease Overview: Arthritis 6
2.2 Treatment Overview: Joint Reconstruction or Replacement 6
2.2.1 Types of Joint Replacement Surgeries 6
3 US Hip and Knee Implants: Market Characterization 8
3.1 US Hip and Knee Replacement Market: Revenues (2000–2015) 8
3.1.1 US Hip and Knee Replacement Market, Historic Revenues (2000–2008): Rising Incidence Of Osteoarthritis Led To Market Growth At 10.5% 8
3.1.2 US Hip and Knee Replacement Market, Forecast Revenues (2008–2015): Growth At 12% Driven By New Surgical Procedures And Trend Towards Early Surgical Intervention 9
4 US Hip and Knee Replacement Market: Drivers and Restraints 11
4.1 US Hip and Knee Replacement Market: Drivers 11
4.1.1 Rising Osteoarthritis Incidence levels due to Aging Population and Changing Lifestyles are expected to drive future procedure volumes 11
4.1.2 Emergence Of New Procedures, Implant Materials and Design To Drive Increasing Patient Demand 12
4.1.3 Lack Of Medical Solutions To Treat End Stage Osteoarthritis to Sustain Surgery Volumes 12
4.1.4 Direct To Consumer Marketing And Increasing Social Acceptance Is Expected To Drive More People To Surgery 12
4.2 US Hip and Knee Replacement Market: Restraints 13
4.2.1 Rising Cost Of Implant Materials Is Likely To Impact Device Prices And Operating Margins 13
4.2.2 Downward Pressure From Hospitals May Lead To Thinning Margins On New Implants 13
4.2.3 Weak Economic Conditions In The US Leading Patients To Defer Surgeries For Elective Procedures 14
5 US Hip and Knee Replacement Market: Trends and Impact Analysis 15
5.1 Market Trends 15
5.1.1 Advanced Implant Materials & Design 15
5.1.2 Procedures 18
5.1.3 Direct to Consumer Marketing 19
5.2 Impact Analysis 19
6 US Hip and Knee Replacement Market: Segment Analysis 21
6.1 US Knee Replacement Market: Revenues (2000–2015) 22
6.1.1 US Knee Replacement Market: Historic Revenues (2000–2008): Improved durability of knee implants drove replacement surgeries in the younger population 22
6.1.2 US Knee Replacement Market, Forecast Revenues (2008–2015): Expected To Be Driven By Advanced Knee Implant Designs and Procedures 23
6.1.3 US Knee Replacement: Treatment Flow Analysis: Low Treatment Seeking Rate Coupled With Low Prescription Levels Account For Largest Patient Leakages 24
6.2 US Knee Replacement Market: Drivers and Restraints 26
6.2.1 Market Drivers 26
6.2.2 Market Restraints 27
6.3 US Hip Replacement Market: Revenues (2000–2015) 27
6.3.1 US Hip Replacement Market, Historic Revenues (2000–2008): Driven By Increased Adoption In Young Adults, Improved Durability And High Surgery Success Rates 27
6.3.2 US Hip Replacement Market, Revenues Forecasts (2008–2015): New Procedures such as Hip Resurfacing To Drive Growth in Procedure Volumes in Younger Adults 28
6.3.3 US Hip Replacement: Treatment Flow Analysis: Largest Patient Leakage for Hip Replacement in 2008 observed at Prescription Level 30
6.4 US Hip Replacement Market: Drivers And Restraints 31
6.4.1 Market Drivers 31
6.4.2 Market Restraints 32
7 Competitive Landscape 33
7.1 Company Profiles 34
7.1.1 Zimmer Holdings, Inc. 34
7.1.2 Stryker Corporation 35
7.1.3 DePuy, Inc. 35
7.1.4 Biomet, Inc. 36
7.1.5 Smith & Nephew Plc 36
7.1.6 Wright Medical Group, Inc. 37
8 US Hip and Knee Replacement Market: Deals Analysis 39
8.1 Mergers and Acquisitions 40
8.1.1 Biomet Acquires Cartilix 40
8.1.2 Cardo Medical Merges With clickNsettle.com 40
8.1.3 Wright Medical Group Acquires Creative Medical Designs 40
8.2 Asset Transactions 2008–2009 40
8.2.1 MiMedx Sells Assets Of LeveL Orthopedics Division To UPex Holdings 40
8.2.2 Schwartz Biomedical Sells BioDuct Meniscal Fixation Device Assets To Stryker 41
8.2.3 Precimed Acquires Chaumont Facility From Depuy 41
8.3 Partnership Agreements 2008–2009 41
8.3.1 Active Implants Enters Into An Agreement With Joint Replacement Instrumentation 41
8.3.2 Anika Therapeutics Enters Into An Agreement With DePuy Mitek 41
8.3.3 Advanced Surgical Design Enters Into Licensing Agreement 42
9 US Hip and Knee Replacement: Pipeline Analysis 43
9.1 Key Pipeline Products 44
9.1.1 ReCap Total Hip Resurfacing System 44
9.1.2 TriboFit Acetabular Buffer 44
9.1.3 BioPoly RS 44
9.1.4 iBalance Axial Knee Realignment System 45
9.1.5 HemiCAP Femoral Condyle 45
9.1.6 Synthetic knee implant 45
10 Appendix 46
10.1 Definitions 46
10.1.1 Hip Replacement 46
10.1.2 Knee Replacement 46
10.2 Acronyms 47
10.3 Research Methodology 47
10.4 Secondary Research 48
10.5 Primary Research 48
10.6 Models 49
10.7 Forecasts 49
10.8 Expert Panels 49
10.9 GlobalData Consulting 49
10.10 Contact Us 50
10.11 Disclaimer 50

1.1 List of Tables
Table 1: Hip and Knee Replacement, US, Revenue ($m), 2000–2008 8
Table 2: Hip and Knee Replacement, US, Revenue ($m), 2008–2015 9
Table 3: US Hip and Knee Replacement Market, Impact analysis 19
Table 4: Joint Reconstruction, US, Segment Revenue Contribution ($m), 2008 21
Table 5: Knee Replacement, US, Revenue ($m), 2000–2008 22
Table 6: Knee Replacement, US, Revenue ($m), 2008–2015 24
Table 7: Hip Replacement, US, Revenue ($m), 2000–2008 28
Table 8: Hip Replacement, US, Revenue ($m), 2008–2015 29
Table 9: Hip Replacement Market, Pipeline Products, US 43
Table 10: Knee Replacement Market, Pipeline Products, US 44

1.2 List of Figures
Figure 2: Hip and Knee Replacement, US, Revenue ($m), 2000–2008 8
Figure 3: Hip and Knee Replacement, US, Revenue ($m), 2008–2015 9
Figure 4: US Hip and Knee Replacement: Market Drivers and Restraints 11
Figure 5: US Hip and Knee Replacement Market: Trends 15
Figure 6: Advanced Implant Materials & Design: Emerging Trends 15
Figure 7: Implant Design: Comparison Between Major Types Of Implants 17
Figure 8: Procedures: Comparison Between Major Types Of Procedures 18
Figure 9: Expected Market Events, Hip and Knee Replacement Market, Impact Analysis, United States 2010–2015 20
Figure 10: Joint Reconstruction, US, Segment Revenue Contribution (Percentage), 2008 21
Figure 11: Knee Replacement, US, Revenue ($m), 2000–2008 22
Figure 12: Knee Replacement, US, Revenue ($m), 2008–2015 23
Figure 13: Treatment Flow Analysis: Knee Osteoarthritis in the US, 2008 24
Figure 14: Growth rates for treatment flow patterns, 2008–2015 26
Figure 15: Hip Replacement, US, Revenue ($m), 2000–2008 27
Figure 16: Hip Replacement, US, Revenue ($m), 2008–2015 28
Figure 17: Treatment Flow Analysis: Hip Osteoarthritis in the US, 2008 30
Figure 18: Growth Rates For Treatment Flow Patterns, Hip Replacement, 2008–2015 31
Figure 19: Market Share of Knee Replacement Market, 2008, US 33
Figure 20: Market Share of Hip Replacement Market, 2008, US 33
Figure 21: Hip and Knee Replacement, Deal Value ($m) and Volume, US, 2008–2009 39
Figure 22: Hip and Knee Replacement, Deal Type, US, 2008–2009 39
Figure 23: GlobalData Methodology 48